(Q33708774)

28 July 2017

title

Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells (English)

1 reference

28 July 2017

Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

25 July 2024

Stefan Sleijfer

1 reference

28 July 2017

Reno Debets

1 reference

28 July 2017

Cor H. J. Lamers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20889925

25 July 2024

Ralph Willemsen

1 reference

28 July 2017

Pascal van Elzakker

1 reference

28 July 2017

Sabine van Steenbergen-Langeveld

1 reference

28 July 2017

Marieke Broertjes

1 reference

28 July 2017

Jeannette Oosterwijk-Wakka

1 reference

28 July 2017

Egbert Oosterwijk

1 reference

28 July 2017

Jan W. Gratama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20889925

25 July 2024

language of work or name

English

0 references

publication date

1 October 2010

1 reference

28 July 2017

6 January 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20889925

full work available at URL

25 July 2024

https://ashpublications.org/blood/article-pdf/117/1/72/1335776/zh800111000072.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20889925

http://www.bloodjournal.org/cgi/content/abstract/117/1/72

25 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20889925

http://ashpublications.org/blood/article-pdf/117/1/72/1335776/zh800111000072.pdf

25 July 2024

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

25 July 2024

1 reference

28 July 2017

volume

117

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

72-82

1 reference

Cancer regression in patients after transfer of genetically engineered lymphocytes

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

The promise and potential pitfalls of chimeric antigen receptors

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity.

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydras

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen G250

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

SYFPEITHI: database for MHC ligands and peptide motifs

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

A greedy algorithm for aligning DNA sequences

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Protein database searches using compositionally adjusted substitution matrices

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Minimizing the immunogenicity of antibodies for clinical application

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues (SDR)-grafting and de-immunization

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Armed replicating adenoviruses for cancer virotherapy

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

CD8(+) T-cell responses to adeno-associated virus capsid in humans

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Immune responses to AAV in clinical trials

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation

25 July 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-07-294520

25 July 2024

Identifiers

DOI

1 reference

28 July 2017

1 reference